EXCLUSIVE: Ampio Pharma Says Statistical Analysis Of Ampion Study For 725 Patients Co. Believes Were Not Impacted By COVID-19 Pandemic Showed Statistical Significant Reduction In Pain (p=0.026) At 12 Weeks vs Saline Control